BioVigilant Systems Inc. Submits Drug Master Files to U.S. FDA for Instantaneous Microbial Detection Systems

Published: Sep 01, 2011

TUCSON, Ariz.--(BUSINESS WIRE)--BioVigilant Systems, Inc. (www.biovigilant.com), inventors of Instantaneous Microbial Detection™, announced today it has filed Type V Drug Master Files (DMFs) for its IMD-A® 300 series of rapid biologic detection systems for real-time environmental air monitoring in pharmaceutical manufacturing environments.

Back to news